Contribution of Rho/Rho-kinase Signalisation Pathway to Gentamicin Induced Nephrotoxicity in Mice


KAPLAN H. M.

INTERNATIONAL JOURNAL OF PHARMACOLOGY, cilt.12, sa.6, ss.617-620, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 6
  • Basım Tarihi: 2016
  • Doi Numarası: 10.3923/ijp.2016.617.620
  • Dergi Adı: INTERNATIONAL JOURNAL OF PHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.617-620
  • Çukurova Üniversitesi Adresli: Hayır

Özet

Background and Objective: One of the main cause of acute renal failure is a minoglycoside nephrotoxicity. Nephrotoxicity is defined as renal failure and tubular necrosis is the evident characteristic of it. Inhibition of Rho-kinase signaling pathway is shown to be useful in preventing the kidney damage caused by diabetes and renal ischemia. Aminoglycoside nephrotoxicity shows similar pathological conditions like diabetes and ischemia. Therefore, a study is planned to examine the effects of gentamicin, which is an aminoglycoside, induced nephrotoxicity on Rho/Rho kinase signalization pathway. Materials and Methods: For this purpose, 100 mg kg (1) gentamicin is administered to mice for 9 days. Then, RhoA and Rho-kinase enzyme concentrations and the activity of Rho-kinase in their kidneys are analyzed by using FLISA method. Results:Gentamicin administration increased the expression of RhoA and Rho-kinase enzymes together with the activity of Rho-kinase. Conclusion: Gentamicin caused an increase in RhoA and Rho-kinase II enzymes in kidneys. It also caused an increase in the activity of Rho-kinase enzymes. Findings of this study suggest that there is a strong correlation between Rho/Rho-kinase pathway and inflamation. In conclusion, this study shows that gentamicin treatment enhanced Rho/Rho-kinase signalization pathway and helps us to understand the molecular mechanism of nephrotoxicity.